Creative Medical Technology Holdings (CELZ) Long-Term Debt Issuances (2010 - 2021)
Creative Medical Technology Holdings (CELZ) posted quarterly Long-Term Debt Issuances of $3.8 million for Q3 2021, up 16959.59% quarter-over-quarter from $22000.0 in Q1 2021.
Creative Medical Technology Holdings (CELZ) Long-Term Debt Issuances (2010 - 2021) Analysis & Trends
Creative Medical Technology Holdings (CELZ) has reported Long-Term Debt Issuances for 11 consecutive years, with $3.8 million the latest figure, recorded in Q3 2021.
- In Q3 2021, Long-Term Debt Issuances changed N/A year-over-year to $3.8 million; the TTM figure through Jun 2022 stood at $3.8 million (changed N/A YoY), while the FY2021 annual figure was $3.9 million, changed N/A from the prior year.
- Long-Term Debt Issuances advanced to $3.8 million in Q3 2021 per CELZ's latest filing, from $22000.0 in the prior quarter.
- Across five years, Long-Term Debt Issuances topped out at $3.8 million in Q3 2021 and bottomed at -$743310.0 in Q3 2018.
- Historically, Long-Term Debt Issuances has averaged $453855.0 across 4 years, with a median of $200750.0 in 2017.
- On a YoY basis, Long-Term Debt Issuances climbed as much as 8575.45% in 2017 and fell as far as 6535.37% in 2017.
- Creative Medical Technology Holdings' Long-Term Debt Issuances stood at -$286250.0 in 2017, then slumped by 159.67% to -$743310.0 in 2018, then surged by 282.0% to $1.4 million in 2019, then jumped by 177.43% to $3.8 million in 2021.
- Business Quant data shows CELZ's Long-Term Debt Issuances at $3.8 million in Q3 2021, $22000.0 in Q1 2021, and $1.4 million in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Creative Medical Technology Holdings | 1.88 Mn | 1.88 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 1.36 Mn |
| Dec 31, 2021 | 1.36 Mn |
| Sep 30, 2021 | 3.75 Mn |
| Sep 30, 2021 | 3.75 Mn |
| Mar 31, 2021 | 22,000.00 |
| Mar 31, 2021 | 22,000.00 |
| Dec 31, 2019 | 1.35 Mn |
| Dec 31, 2019 | 1.35 Mn |
| Sep 30, 2019 | -739,890.00 |
| Sep 30, 2019 | -739,890.00 |
| Jun 30, 2019 | 114,000.00 |
| Jun 30, 2019 | 114,000.00 |
| Mar 31, 2019 | 575,890.00 |
| Mar 31, 2019 | 575,890.00 |
| Sep 30, 2018 | -743,310.00 |
| Sep 30, 2018 | -743,310.00 |
| Jun 30, 2018 | 488,960.00 |
| Jun 30, 2018 | 488,960.00 |
| Mar 31, 2018 | 254,350.00 |
| Mar 31, 2018 | 254,350.00 |